
Pro Medicus shares are down 5.8% in 2025. The healthcare imaging software provider relies on subscription revenue and U.S. hospital contracts. Half-year results are due in February.
Pro Medicus shares have fallen 5.8% since the start of 2025. The company, founded in 1989, builds medical imaging software used by hospitals and radiology clinics. It sells subscriptions, which produce recurring revenue.
Healthcare IT companies have benefited from hospital spending on digital tools. Pro Medicus has won large contracts in the U.S., including an agreement with the Department of Veterans Affairs. That contract helped drive a 40% share price gain in 2024.
The recent decline brings Pro Medicus's market value to roughly A$8 billion. The company has not announced any new contracts so far in 2025. Its half-year financial results are due in February. The company has not provided guidance for the full year.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.